Enoxaparin sodium
- Generic Name
- Enoxaparin sodium
- Brand Names
- Lovenox, Inhixa
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 9005-49-6
- Unique Ingredient Identifier
- E47C0NF7LV
- Background
Enoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies. Enoxaparin markedly reduces the incidence of venous thromboembolism in hosp...
- Indication
Enoxaparin is indicated for the prevention of ischemic complications in unstable angina and in non Q-wave myocardial infarction; it is indicated in conjunction with percutaneous intervention and/or other treatment for the management of acute ST elevation myocardial infarction.
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Acute Myocardial Infarction With ST Segment Elevation, Deep Vein Thrombosis, Ischemic complications caused by non-q wave myocardial infarction, Ischemic complications caused by unstable angina
- Associated Therapies
- Percutaneous Coronary Intervention (PCI)
Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 7212
- Registration Number
- NCT02600260
- Locations
- 🇧🇷
University of Sao Paulo General Hospital, Sao Paulo, Brazil
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2019-12-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT02589145
- Locations
- 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose
- First Posted Date
- 2015-07-01
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT02486666
- Locations
- 🇨🇦
IWK Health Center, Halifax, Nova Scotia, Canada
🇨🇦HHSC/McMaster Children's Hospital, Hamilton, Ontario, Canada
🇨🇦Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2023-05-09
- Lead Sponsor
- Tampere University Hospital
- Target Recruit Count
- 85
- Registration Number
- NCT02474212
- Locations
- 🇫🇮
Tampere University Hospital, Tampere, Pirkanmaa, Finland
Enoxaparin Metabolism in Reconstructive Surgery Patients
- Conditions
- Interventions
- First Posted Date
- 2015-04-08
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 110
- Registration Number
- NCT02411292
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
PROphylaxis in NOn Major Orthopaedic Surgery
- Conditions
- Interventions
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2018-12-07
- Target Recruit Count
- 3608
- Registration Number
- NCT02401594
- Locations
- 🇫🇷
CHU AMIENS Picardie, Amiens, France
🇫🇷CHU Angers, Angers, France
🇫🇷Clinique Générale d'ANNECY, Annecy, France
Aspirin and Enoxaparin for VTE in Trauma
- Conditions
- Interventions
- First Posted Date
- 2015-03-24
- Last Posted Date
- 2019-11-19
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 31
- Registration Number
- NCT02396732
- Locations
- 🇺🇸
Ryder Trauma Center, Miami, Florida, United States
Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2016-04-29
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT02389582
- Locations
- 🇧🇷
InCor Heart Institute, São Paulo, Brazil
The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- University Hospital, Brest
- Target Recruit Count
- 2560
- Registration Number
- NCT02379806
- Locations
- 🇫🇷
CH Public du Cotentin, Cherbourg, France
🇫🇷CH Louis Mourier de Colombes, Colombes, France
🇫🇷CHD Vendée, La Roche Sur Yon, France
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 639
- Registration Number
- NCT02379663
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.